Dusseldorf - Delayed Quote EUR
AbbVie Inc (4AB.DU)
154.80
+4.00
+(2.65%)
At close: April 23 at 7:30:14 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
18,806,000
18,806,000
22,839,000
24,943,000
22,777,000
Investing Cash Flow
-20,820,000
-20,820,000
-2,009,000
-623,000
-2,344,000
Financing Cash Flow
-5,211,000
-5,211,000
-17,222,000
-24,803,000
-19,039,000
End Cash Position
5,524,000
5,524,000
12,814,000
9,201,000
9,746,000
Income Tax Paid Supplemental Data
4,064,000
4,064,000
4,702,000
2,988,000
3,648,000
Interest Paid Supplemental Data
2,811,000
2,811,000
2,469,000
2,546,000
2,712,000
Capital Expenditure
-974,000
-974,000
-777,000
-695,000
-787,000
Issuance of Debt
21,971,000
21,971,000
--
2,000,000
1,000,000
Repayment of Debt
-14,621,000
-14,621,000
-4,149,000
-14,433,000
-9,414,000
Repurchase of Capital Stock
-1,708,000
-1,708,000
-1,972,000
-1,487,000
-934,000
Free Cash Flow
17,832,000
17,832,000
22,062,000
24,248,000
21,990,000
12/31/2021 - 2/20/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade